Structure-Based Discovery of the Novel Antiviral Properties of Naproxen against the Nucleoprotein of Influenza A Virus

Supplemental material

Files in this Data Supplement:

• Supplemental file 1 -

  Supplemental Figures S1 (supplemental MD data), S2 (supplemental SPR data), S3 (naproxen protection against proteolytic cleavage of NP), S4 (IF data), S5 (in vivo protocol), and S6 (representative bronchoalveolar fluids of infected, infected and treated, and uninfected mice).

  PDF, 794K

• Supplemental file 2 -

  Supplemental movie of the MD simulations of the NP-naproxen complex.

  AVI, 17M